Company Hires Accomplished New Regional Sales Directors
RESEARCH TRIANGLE PARK, NC, MAY 1, 2013 – Zylera Pharmaceuticals, LLC, a specialty pharmaceutical company that develops, acquires and commercializes prescription pharmaceutical products and dietary supplements and markets those products in the U.S. is pleased to announce the appointment of Edward Boylan and Rad Mignerey as Regional Sales Directors for the West and East, respectively.
“Both Ed and Rad bring a plethora of successful pharmaceutical sales leadership experience to Zylera during a time of growth,” said Robert Moscato, President. “Their focus on execution and accountability will help Zylera introduce new medications that improve patients’ lives, maximize value and partner with high performing organizations while maintaining a lean and efficient operating model.”
Edward Boylan has over 22 years of pharmaceutical industry experience. Ed began his career as a field sales representative with Janssen Pharmaceuticals. He has held progressive leadership positions in field sales management as a Trainer, District Manager and Regional Sales Director for Eisai, Inc. He has extensive experience in start-up operations, product launches, sales force expansions, integration and development. Sector experience includes long term care, assisted living, hospitals and pharmacy providers, managed markets and federal account management. Ed was part of the inaugural management team as a Regional Sales Manager for Somaxon Pharmaceuticals, and most recently as a District Manager on the Amylin Synergy team that launched the only once weekly injectable for Type II diabetes. He holds a BA degree from the Virginia Military Institute and an MBA in Pharmaceutical Marketing from Saint Joseph’s University. Ed is also a retired Lieutenant Colonel in the United States Army Reserve.
Rad Mignerey has more than 15 years of pharmaceutical industry experience. He brings a robust track record of performance and leadership across many pharmaceutical sales teams and shared services functions including: Oncology, Gastroenterology, Neurology, Pediatrics and Incentive Compensation design and implementation. Rad has held leadership positions at Upjohn Pharmaceuticals, Eisai, Archimedes Pharma, and InVentiv Health. Rad holds a BA degree from Flagler College in St. Augustine, FL.
Company Hires Seasoned Executive In Parallel With New Product Launches
Research Triangle Park, NC, November 15, 2011 — Zylera Pharmaceuticals, LLC, a specialty pharmaceutical company that develops, acquires and commercializes prescription pharmaceutical products and dietary supplements and markets those products in the U.S. is pleased to announce the appointment of Matthew V. Phillips as Chief Operating Officer.
Prior to joining Zylera Matt was Executive Director of Managed Markets for Victory Pharma Inc., contributing to the growth of that company from a modest start up to a respected organization with over $100 Million in revenue. At Victory, Matt was responsible for several areas of operations including Trade/Distribution, Government Accounts, Managed Markets, and Strategic Accounts. Matt brings with him a solid base of experience and an impressive history of building high performing partnerships in diverse markets while effectively promoting numerous products in multiple therapeutic areas. Matt’s previous experience includes sales, management and executive leadership positions in the home health care industry and within the pharmaceutical industry through positions at Dura Pharmaceutical, Eisai and Victory Pharma.
“We are incredibly excited to have Matt join our team. He brings an entrepreneurial spirit and work ethic along with a proven track record of success and resilience,” said President Robert Moscato. “Matt’s plethora of experience in new product launches and commercialization makes him a natural fit. He will help Zylera maximize value and partner with high performing organizations while maintaining a lean and efficient operating model.”
For more information visit www.zylera.com or firstname.lastname@example.org.
Zylera Pharmaceuticals Launches New Corporate Website
Research Triangle Park, NC, August 8, 2011 — Zylera Pharmaceuticals, LLC, a specialty pharmaceutical company that develops, acquires and commercializes prescription pharmaceutical products and dietary supplements and markets those products in the U.S. is pleased to announce the launch of its new corporate website www.zylera.com. The site was developed to provide potential business partners with an overview of the company, its management and strategic priorities.
Media Contact: BD@Zylera.com